Facebook Instagram Linkedin Youtube
Home Search

iconovo - search results

If you're not happy with the results, please do another search
Arcede Pharma prepareds for phase I

Arcede aims for clinic with TO1

BIO-Europe

Busy days for Iconovo at BIO-Europe

Toleranzia stegar på

Arcede proceeds to stability study in collaboration with Iconovo

LSX Nordic Congress Interviews

Interviews from LSX Nordic Congress 

Iconovo welcomes Gerald Engström as largest shareholder through share issue

Intervjubanner_BIMSeptember2023

Watch the interviews from BioStock Investor Meeting!

Companypresentations_BIM2023Sept

Watch the presentations from BioStock Investor Meeting!

Iconovo

Iconovo makes progress in the outlicensing process for ICOpre 

Iconoco

Iconovo on the way to profitability

Iconovo

Iconovo initiates collaboration with Affilogic

Iconovo

Iconovo launch Accelerator Program

Iconovo

Iconovo initiates structured sales process for ICOpre

Arcede heading towards dosing in tox study

Arcede approaching dosing in tox study

Iconovo

Iconovo’s oxytocin treatment in clinical phase I study

Arcede Pharma och Iconovo

Arcede Pharma and Iconovo receive funding from Swelife

Arcede Pharma släpper sin Q3-rapport

Arcede Pharma looks ahead with strengthened team

Iconovo

Iconovo carries out directed share issue for continued value creation

Iconovo

Iconovo starts 2023 with negotiations for ICOpre

Several big patents to expire 2023

Several blockbuster patents to expire in 2023

The value of patent protection in life science

The value of patent protection in life science

Arcede Pharma is preparing for clinical studies

Arcede Pharma prepares for clinical studies

Fredrik Radencrantz

Iconovo establishes Nordic pharmaceutical sales

Iconovo

Iconovo reports Q3 and arranges pandemic event

Iconovo

Iconovo’s journey told by co-founder Orest Lastow

Arcede Pharma releases its first quarterly report

Arcede Pharma reports on the first quarter

Mia Lundblad, CEO Arcede Pharma

Arcede Pharma’s CEO is ready for Spotlight

BioStock Life Science Spring Summit

Watch day 2 of the BioStock Life Science Spring Summit

The BioStock Life Science Spring Summit starts now

Respiratorius to split into two companies

Focus on company split for Respiratorius during Q4

BioStock life science spring summit 2022

BioStock Life Science Spring Summit, June 8-9, 2022

Respiratorius

Strong start to 2022 for Respiratorius

BIO-Europe

Eight CEOs on their expectations at BIO-Europe

Respiratorius’ RCD405 shows efficacy in preclinical study

Respiratorius’ RCD405 shows efficacy in preclinical study

Iconovo looks to the US where it now meets quality requirements

Patent approval stamp

Patent approved for Respiratorius’ COPD project

Iconovo’s partner explores opportunities in Bangladesh

Iconovo receives order for nasal Covid-19 vaccine development

Iconovo participates in vaccine race

The future of inhalation devices: making products more user-friendly

Biggest investment in Iconovo’s history

Iconovo’s new collaboration aims to optimise current inhalation products

Iconovo met innovation companies at BIO-Europe

Directed share issue of 60 million SEK to finance Iconovo’s new...

Spray inhalers – a major climate change culprit according to a...

Iconovo aims for more innovations in inhalation

New CEO gives Iconovo sharper focus

Video interview: Iconovo’s CEO presented the company at the LSX World...

Year-end report spotlights healthy progress for Iconovo

Iconovo’s CEO comments on the capital raise

High potential with Iconovo’s new inhalation platform ICOpre

Iconovo marginally impacted by Coronavirus pandemic

World TB Day: Iconovo’s ICOone platform in the spotlight

Iconovo boosts patent protection for ICOone

Analysts see high value in Iconovo’s business

New partnership adds support to development of Iconovo’s Symbicort generic

Iconovo’s ICOcap inhaler receives CE marking

Iconovo in collaboration with Malmö​​​​​​​ University

Iconovo strengthens international intellectual property

Iconovo adds business development experience with new CEO

Deal gives Iconovo long-term revenue potential

12Page 1 of 2
© BioStock 2024